Sanofi, GSK Covid-19 vaccine to be ready only at the end of 2021 

Kaveri Nadan  Saturday 12th of December 2020 03:03 AM
(0) (0)


 
Sanofi and GSK announced a delay in their adjuvanted recombinant protein-based Covid-19 vaccine programme to improve immune response in older adults, pushing the vaccine’s potential availability from mid-2021 to Q4 2021.

 

Leave Your Response